We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cambridge Nutritional Sciences Plc | LSE:CNSL | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.15 | 4.00 | 4.30 | 4.15 | 4.15 | 4.15 | 369,268 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | 8.19M | -3.86M | -0.0162 | -2.56 | 9.86M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/3/2024 11:40 | This is ready to pop, looks like they have just 50,000 shares left at offer price. A hidden gem stock in a growth sector -> Nutrition. Can see this really flying with news. | one2go | |
19/3/2024 10:05 | Just 100k on offer now at 3.2p then it moves up. | broken_arrow1 | |
19/3/2024 09:47 | This was posted on Twitter recently, the last broker coverage that offered a target price of 12p a share. Recent coverage suggested they valued the Health business at £25m, so just over 10p a share. Both a long way from the current 3p ! | thecoyone | |
19/3/2024 09:32 | Most brokers are 'at best' this morning, looks like they are trying to fill an order. The chart breakout from a well established range is significant. 3.4p for 100k+ is being asked by IG currently although recently their prices fluctuate wildly in this stock for some reason. | broken_arrow1 | |
19/3/2024 09:19 | This is a bagger in the making, sod all online, asking 3.4p v 3.2p offer for just £5k's worth now. Broker has TP 12p a share. Totally under the radar, the sector is booming. | one2go | |
18/3/2024 10:36 | Now only 100k on the offer at 3.19p then it moves to 3.4p Book is very strong. Chart breakout also. | broken_arrow1 | |
18/3/2024 09:03 | Very positive about this company and no wonder buyers are coming in. The investment proposition is compelling, cash £4.4m, growth & higher margins, revenues increasing, costs down, established and growing customer base, new markets including USA, Middle East, already established in China and Europe. All this for a sub £7m company, should be double that as a bare minimum. No wonder the last price target was north of 10p a share. | thecoyone | |
18/3/2024 08:06 | Market opens here with 250k on offer at 3.07p then it goes to full offer at 3.2p one market maker sits at 3.4p a quite large premium. All indicators are positive from a technical perspective with 4p as a first target. | broken_arrow1 | |
15/3/2024 16:16 | Book is strengthening towards the close, would not rule out a run to 4p next week. | broken_arrow1 | |
15/3/2024 07:55 | Looks like the CEO (4th from left seated) has been doing some discreet promotion in the City, possibly explains the increased interest here. With circa £4.5m in the bank, a market cap of only £6.75m, growing £10m+ revenues & higher margins no wonder the share price is moving up | thecoyone | |
14/3/2024 15:46 | Now asking 3.13p for 100k, book is strengthening again. | broken_arrow1 | |
14/3/2024 09:02 | Just 100k of shares on offer at 3.07p then they move it up. Profit taking yesterday clearly absorbed. | broken_arrow1 | |
14/3/2024 08:11 | Results today from Abingdon Health show the sector is returning back to health, this has to be good for all participants, especially the smaller companies whose share prices have been battered down. I think CNSL is one of the best plays for capital appreciation in the sector starting from a very low base, their cash position is exceptional around £4m, how many AIM listed outfits would like that number in their bank. If all goes to plan I expect to see the share price above 10p by year end, my only concern, as mentioned before, is a low ball takeover approach but the BOD have stated it would need to be at a significant premium to market to be considered. Fact is the shares are cheap (£6.5m m/cap), very cheap, no wonder it is very difficult to get a meaningful slice. | thecoyone | |
14/3/2024 07:51 | 4p by month end, I say that is a minimum.... | one2go | |
13/3/2024 13:58 | The market makers would have you believe they have plenty of stock at 3.1p, they haven't ! Premium being asked for anything over 100k of shares. | broken_arrow1 | |
13/3/2024 09:15 | New all-time highs (well, for CNSL if not ODX!). Agreed thecoyone, extremely undervalued imo too. | rivaldo | |
13/3/2024 09:14 | Only 150k available at 3.2p then they want 3.4p. The 3.75p chart gap fill remains in sight. | broken_arrow1 | |
13/3/2024 08:39 | I am hardly surprised by the price movement the company is materially undervalued on so many metrics, the cash balance is exceptional for a junior, currently north of £4m verses a market valuation of £6.5m. Recent Linkedin posts show strong interest in product offerings promoted in Dubai and Europe, at current levels Cambridge is wide open for a takeover approach. The gut health sector has annual revenues of $40b, this company is leading the way. Sales revenues for FY are likely to exceed £10m IMO, ahead of forecasts. | thecoyone | |
13/3/2024 08:08 | No quotes available at 3p, IG are asking 3.29p for just 100,000 shares ! | broken_arrow1 | |
13/3/2024 07:53 | Someone took 125k right at the close and took all the remaining stock on offer at 3p. Looks like the share price strength will continue today therefore. That 3.75p chart gap still needs filling, possibly today. | broken_arrow1 | |
12/3/2024 16:24 | 3.3p now being asked for just £4000 worth !!! | one2go | |
12/3/2024 16:20 | Definitely something going on here, a trading statement maybe, last two years have been in Jan and April. Even at 5p a share the company would only be valued at £12m with £4m in cash. | one2go | |
12/3/2024 15:58 | Just £3k of stock available at 3p then it goes to 3.15p | broken_arrow1 | |
12/3/2024 15:31 | Cant buy online, just saw this on Twitter.... Just retweeted by ZM, he is well followed | silverspoon2009 | |
12/3/2024 15:21 | Book continues to strengthen behind the scenes. | broken_arrow1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions